Celltrion
068270.KS
#746
Rank
A$46.71 B
Marketcap
A$213.54
Share price
1.40%
Change (1 day)
14.18%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

EPS for Celltrion (068270.KS)

EPS in 2025 (TTM): A$2.88

According to Celltrion 's latest financial reports the company's current EPS (TTM) is A$2.72. In 2024 the company made an earnings per share (EPS) of A$1.93 a decrease over its 2023 EPS that were of A$3.82.

EPS history for Celltrion from 2007 to 2025

Annual EPS

Year EPS Change
2025 (TTM)A$2.8849.48%
2024A$1.93-49.57%
2023A$3.82-2.08%
2022A$3.90-11.72%
2021A$4.422.03%
2020A$4.3382.8%
2019A$2.3718.31%
2018A$2.00-36.33%
2017A$3.15161.25%
2016A$1.202.86%
2015A$1.1717.84%
2014A$0.995.87%
2013A$0.94-70.85%
2012A$3.22134.09%
2011A$1.3743.59%
2010A$0.9674.49%
2009A$0.55317.8%
2008A$0.13-71.7%
2007A$0.46